Details for New Drug Application (NDA): 090363
NDA 090363 describes DESFLURANE, which is a drug marketed by Piramal Critical and Shanghai Hengrui and is included in two NDAs. It is available from two suppliers. Additional details are available on the DESFLURANE profile page.
The generic ingredient in DESFLURANE is desflurane. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
The generic ingredient in DESFLURANE is desflurane. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.
Summary for 090363
| Tradename: | DESFLURANE |
| Applicant: | Piramal Critical |
| Ingredient: | desflurane |
| Patents: | 0 |
Pharmacology for NDA: 090363
| Physiological Effect | General Anesthesia |
Suppliers and Packaging for NDA: 090363
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DESFLURANE | desflurane | LIQUID;INHALATION | 090363 | ANDA | Piramal Critical Care Inc | 66794-021 | 66794-021-35 | 6 BOTTLE in 1 CARTON (66794-021-35) / 250 mL in 1 BOTTLE (66794-021-20) |
| DESFLURANE | desflurane | LIQUID;INHALATION | 090363 | ANDA | Piramal Critical Care Inc | 66794-021 | 66794-021-40 | 6 BOTTLE, GLASS in 1 CARTON (66794-021-40) / 250 mL in 1 BOTTLE, GLASS (66794-021-25) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | LIQUID;INHALATION | Strength | 100% | ||||
| Approval Date: | Oct 5, 2026 | TE: | AN | RLD: | No | ||||
Complete Access Available with Subscription
